The Effectiveness of Mini‐Pulse Methylprednisolone in the Treatment of Patients With COVID‐19 in the Intensive Care Unit
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.70071 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Yousef Mohammadi-Kebar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. Hauptthemen laut MEDLINE: Methylprednisolone, Intensive Care Units, COVID-19 Drug Treatment, COVID-19. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Objective
To investigate the effect of mini‐pulse methylprednisolone in the treatment of patients with COVID‐19 hospitalized in the intensive care units (ICU).
Methods
This is a single‐blind parallel non‐randomized clinical trial that will be carried out on 60 hospitalized COVID‐19 patients and conducted between February 2020 and December 2020 in Ardabil City Hospital, Ardabil, Iran. The t ‐test and chi‐square test were used to compare the results of the two groups. A p ‐value of less than 0.05 was considered statistically significant. Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 26 software.
Results
The mean (±SD) age of patients was 57.53 ± 13.71 years. Thirty‐five patients (58.3%) were male and 25 (14.7%) were female. Twenty‐eight patients had fever. During admission, the mean (±SD) of the oxygen saturation was 80.73 ± 8.31. No significant relationship was observed between the study variables in the two groups at baseline.
Conclusion
The results of the present study showed that in patients treated with methylprednisolone, blood oxygen saturation increased and heart rate and breathing rate decreased significantly. Also, mini‐pulse treatment with methylprednisolone significantly reduced the number of days of hospitalization and the incidence of mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Infection Diseases, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Anesthesiology and Intensive Care Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
ORCID-Profile: Yousef Mohammadi-Kebar, Saeid Hoseininia
Zitieren
APA
Mohammadi-Kebar, Y., Habibzadeh, S., Hoseininia, S., Ghobadi, H., Samadi, A., Mohammadikebar, S., Azami, A., Fouladi, S., Amani-Marani, Y., & Habibzadeh, A. (2024). The Effectiveness of Mini‐Pulse Methylprednisolone in the Treatment of Patients With COVID‐19 in the Intensive Care Unit. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70071
Vancouver
Mohammadi-Kebar Y, Habibzadeh S, Hoseininia S, Ghobadi H, Samadi A, Mohammadikebar S, et al. The Effectiveness of Mini‐Pulse Methylprednisolone in the Treatment of Patients With COVID‐19 in the Intensive Care Unit. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70071
BibTeX
@article{MohammadiKebar2024,
author = {Mohammadi-Kebar, Yousef and Habibzadeh, Shahram and Hoseininia, Saeid and Ghobadi, Hasan and Samadi, Alihossein and Mohammadikebar, Sousan and Azami, Ahad and Fouladi, Shahnaz and Amani-Marani, Yousef and Habibzadeh, Afshin},
title = {The Effectiveness of Mini‐Pulse Methylprednisolone in the Treatment of Patients With COVID‐19 in the Intensive Care Unit},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.70071}
}
EUVIMED